PROFIT FROM DEATH: OxyContin consultant suggested paying BONUSES to distributors for each drug overdose as part of sales “turbocharge” strategy | WHAT REALLY HAPPENED

PROFIT FROM DEATH: OxyContin consultant suggested paying BONUSES to distributors for each drug overdose as part of sales “turbocharge” strategy

Court documents released last week under Purdue Pharma’s bankruptcy process reveal that that consultancy firm McKinsey & Company advised its client to pay rebates to distributors of OxyContin whenever an overdose case could be traced back to abuse of the controversial opioid pill.

The purpose of these kickbacks or bonuses was to help “turbocharge” Purdue’s sales of the deadly drug, thus producing higher profits for the pharmaceutical giant amid escalating scrutiny over its illicit marketing and sales practices.

Though the Trump administration reportedly cut a deal with the Sackler family, which runs Purdue, to protect them from criminal liability, the company has reportedly agreed to plead guilty to criminal charges over the way it peddled OxyContin to the masses.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA